SEC Form 4 · accession 0001209191-18-051149
TRANSENTERIX INC. · TRXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William N Starling Jr.
Director
Period of report
Sep 13, 2018
Accepted (ET)
Sep 14, 2018 · 7:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 13, 2018 | J | 156,384 | — | D | 235,738 | I | See Footnote |
| Common StockF1,F2 | Sep 13, 2018 | J | 78,192 | — | A | 213,415 | I | By Trust |
| Common StockF3 | holding | — | — | — | 5,318,969 | I | See Footnote | |
| Common Stock | holding | — | — | — | 66,987 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Synecor, LLC distributed an aggregate of 156,384 shares of TransEnterix stock to its officers in satisfaction of guaranteed payments. The reporting person is the chief executive officer of Synecor, LLC. The reporting person received 78,192 of such shares.
- F2Shares of Common Stock held by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990.
- F3Shares of Common Stock held by Synergy Life Science Partners, L.P. William N. Starling is a managing director of Synergy Life Science Partners, L.P.